Compare CORT & ONON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CORT | ONON |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.4B |
| IPO Year | 2001 | 2021 |
| Metric | CORT | ONON |
|---|---|---|
| Price | $113.05 | $27.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 20 |
| Target Price | ★ $96.50 | $60.15 |
| AVG Volume (30 Days) | 805.4K | ★ 9.0M |
| Earning Date | 04-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $761,407,000.00 | N/A |
| Revenue This Year | $26.08 | $19.58 |
| Revenue Next Year | $26.98 | $19.98 |
| P/E Ratio | $1,259.44 | ★ $56.05 |
| Revenue Growth | ★ 12.79 | N/A |
| 52 Week Low | $28.66 | $28.21 |
| 52 Week High | $126.38 | $51.08 |
| Indicator | CORT | ONON |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 27.11 |
| Support Level | $77.73 | N/A |
| Resistance Level | $122.21 | $38.73 |
| Average True Range (ATR) | 4.04 | 0.91 |
| MACD | -1.68 | -0.21 |
| Stochastic Oscillator | 15.22 | 1.93 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Founded in Switzerland in 2010, sportswear firm On Holding generates more than 90% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of 2025 sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.